What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹15 Cr over the trailing twelve months.
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from Achyut Healthcare Limited's filed financials and exchange disclosures
Achyut Healthcare Limited is a Pharmaceuticals & Biotechnology company listed on BSE.
Not in the latest reported year — Achyut Healthcare Limited's dividend payout for FY26 was nil.
Effectively yes. It holds ₹3 Cr more cash than debt. Debt stands at 0.00× equity.
On trailing P/E, Achyut Healthcare Limited ranks 166 of 169 in Pharmaceuticals — cheaper than 2% of them, against an industry median of 28.9×. This is a position, not a valuation judgement.
On a typical session Achyut Healthcare Limited moves 1.91% — that is the median absolute close-to-close move across its last 248 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by Achyut Healthcare Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
